USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: STC BIOLOGICS, INC
Address: 763 D Concord Ave
CAMBRIDGE, MA 02138
Located in HUBZone: No
Woman-Owned: Yes
Minority-Owned: No
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $299,881.00 1
SBIR Phase II $2,499,488.00 1

Award List:

Not Available

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Magdalena Leszczyniecka – (617) 899-0724
Award Amount: $299,881.00
Abstract:
The goal of this project is to develop STC trastuzumab, a generic version of Herceptin. Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients with breast cancer. Because of very high cost associated with prescribing Herceptin, a generic… More

IGF::OT::IGF SBIR PHASE II TOPIC 275, DEVELOPMENT OF GENERIC TRASTUZUMAB FOR THE TREATMENT OF BREAST CANCER.

Award Year / Program / Phase: 2012 / SBIR / Phase II
Agency: HHS
Principal Investigator: Magdalena Leszczyniecka – 617-899-0724
Award Amount: $2,499,488.00
Abstract:
The goal of this project is to develop STC101, a biosmilar Herceptin . Trastuzumab is a monoclonal antibody made against the HER2 protein that is overexpressed in 20-25% of patients with breast cancer. Because of high cost associated with prescribing Herceptin , a generic version of this drug would… More